Abstract
We determined the rate of change of bone mineral content (BMC) in the distal forearm of 89 healthy postmenopausal women by single-photon absorptiometry. The BMC measurements were taken at 6- or 12-monthly intervals for up to 4 years. Urinary oestrogen excretion and anthropometry were assessed at the time of the first BMC measurement. Urinary oestradiol glucuronide (E2G) excretion was related to the rate of change of ‘proximal’ BMC in women 1–7 years past the menopause (r=0.52,p<0.01). Body mass index was less highly correlated with the rate of change of BMC in these women (r=0.41,p<0.05). We conclude that urinary E2G excretion could contribute to a screening procedure for the assessment in women soon after the menopause of the risk of osteoporotic fracture in later life.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Christiansen C, Riis BJ, Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987;1:1105–8.
Slemenda C, Hui SL, Longcope C, Johnston CC. Sex steroids and bone mass: a study of changes about the time of menopause. J Clin Invest 1987;80:1261–9.
van Hemert AM, Birkenhäger JC, de Jong FH, Vandenbroucke JP, Valkenburg HA. Sex hormone binding globulin in postmenopausal women: a predictor of osteoporosis superior to endogenous oestrogens. Clin Endocrinol 1989;31:499–509.
Hutton JD, Jacobs HS, James VHT. Steroid endocrinology after the menopause: a review. J R Soc Med 1979;72:835–41.
Rae MH, Mole PA, Paterson CR. Evaluation of urinary oestrogen assays after the menopause and their potential for screening. Clin Chim Acta 1988;176:71–81.
Rae MH, Mole PA, Paterson CR. Endogenous factors affecting bone mineral content in postmenopausal women. Maturitas 1991;13:319–24.
Nilas L, Borg J, Gotfredsen A, Christiansen C. Comparison of single- and dual-photon absorptiometry in postmenopausal bone mineral loss. J Nucl Med 1985;26:1257–62.
Mole PA, Rae MH, Paterson CR. Urinary oestrogen excretion after the menopause in relation to age and body mass. Ann Nutr 2Metab 1989;33:246–51.
Thomson J. Patient anthropometric assessment and storage utilizing a cheap microcomputer system. Br J Pharmacol 1984;83:462P.
Nilas L, Christiansen C. The pathophysiology of peri- and postmenopausal bone loss. Br J Obstet Gynaecol 1989;96:580–7.
Christiansen C, Riis BJ, Rodbro P. Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporosis Int 1990;1:35–40.
Delmas PD. Clinical use of biochemical markers of bone remodeling in osteoporosis. In: Christiansen C, Overgaard K, editors. Osteoporosis 1990. Copenhagen: Osteopress, 1990:450–8.
Johansen JS, Riis BJ, Delmas PD, Christiansen C. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 1988;18:191–5.
Yasumura S, Aloia JF, Gundberg CM, et al. Serum osteocalcin and total body calcium in normal pre- and postmenopausal women and postmenopausal osteoporotic patients. J Clin Endocrinol Metab 1987;64:681–5.
Gardsell P, Johnell O, Nilsson BE. Predicting fractures in women by using forearm bone densitometry. Calcif Tissue Int 1989;44:235–42.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walkinshaw, M.H., Mole, P.A. & Paterson, C.R. Potential value of urinary oestrogen assays in the identification of fast bone losers after the menopause. Osteoporosis Int 2, 205–209 (1992). https://doi.org/10.1007/BF01623929
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01623929